Hameln Pharma Ltd
- Large
- Active
- 53 years
- 29 employees
- £14,842,372 (assets)
- £24,513,442 (revenue)
- Real address
- 2 directors
- 1 owner
- Regular importer
- Regular exporter
- Rating 4.0 (1)
Two conditions of three:
1.Turnover > £36 million
2.Balance sheet total > £18 million
3.Average number of employees > 250
Field of Operation
Website
Social media
Phones
Summary
Hameln Pharma Ltd, based in Gloucester, UK, is a large, active pharmaceutical company established 53 years ago. Employing 29 people and boasting assets of £14.8 million, the company generates an annual revenue of £24.5 million. With two directors and one owner, it maintains a Google rating of 4.0 based on one review. The company regularly imports and exports pharmaceutical products, having done so for 72 and 57 months respectively.
The company’s website reveals a focus on generic injectable medicines, with a wide range of products used in hospitals and medical practices. Hameln Pharma operates globally, with companies in nine countries, including the UK, Denmark, and Australia. The website highlights the company’s commitment to quality and reliability, emphasizing its experience in the field of opioids and critical care products. It also details a robust supply chain and intelligent packaging design.
Financially, Hameln Pharma Ltd shows some concerning trends. Accrued liabilities and deferred income increased by 45%, while cash and cash equivalents dropped by a significant 64%. Bank borrowings surged by 2,400%, reaching £29,000, and cash reserves fell 30% to £28,000. On the upside, creditors decreased by 18%, suggesting better debt management. Administrative expenses rose by 57%, and the company’s net assets declined by 34%. While the company meets two of three criteria to be considered a large company, the decline in cash reserves and the rise in liabilities suggest potential financial pressures. The lack of an auditor mentioned (likely exempt as a small company) means the figures rely on unaudited statements.
Despite these challenges, Hameln Pharma’s global presence and focus on essential medicines suggest a resilient business model. The company’s commitment to quality and its wide range of products position it well to serve the healthcare industry, but it will need to address its financial trends to ensure long-term sustainability.
Registered in England/Wales under the registration number 01034697, with a registered address at GL3 4AG, Gloucester, Gloucestershire, Nexus Hurricane Road, Gloucester Business Park.
WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Owners & PSC
-
Individual
- Kerstein Christoph
- 9 years
- 3
- 75%+
- 🇩🇪
Resident of Germany
Managers
-
Individual
- Watkin Stephen Allen
- 2 years
- 3
- 🇬🇧
Resident of United Kingdom
-
Individual
- Kueter Beate
- 3 years
- 🇩🇪
Resident of Germany
Last reports
The latest confirmation statement submitted eleven months ago.
Last news
-
Full accounts made up to 2023-12-31Download 30 pages pdf report
-
Confirmation statement made on 2024-05-13 with no updatesDownload 3 pages pdf report
-
Full accounts made up to 2022-12-31Download 28 pages pdf report
Importer profile by HS codes
Last imported products
Similar importers
- Company names
- HS codes
- Financial data
- Officers and owners
Exporter profile by HS codes
Last exported products
Similar exporters
- Company names
- HS codes
- Financial data
- Officers and owners
FAQ about Hameln Pharma Ltd
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!